Valuation: OneSource Specialty Pharma Limited

Market Cap 161B 1.7B 1.51B 1.4B 1.28B 2.41B 2.44B 16.85B 6.6B 84.24B 6.38B 6.25B 269B P/E 2027 *
34.8x
P/E 2028 * 16.8x
Enterprise Value 170B 1.79B 1.59B 1.48B 1.35B 2.54B 2.58B 17.77B 6.97B 88.87B 6.73B 6.59B 283B EV / Sales 2027 *
7.81x
EV / Sales 2028 * 4.78x
Free-Float
64.51%
Yield 2027 *
-
Yield 2028 * -
1 day-1.77%
1 week-3.66%
Current month-7.48%
1 month-10.90%
3 months-14.84%
6 months-8.79%
Current year-22.25%
1 week 1,401.9
Extreme 1401.9
1,503.9
1 month 1,401.9
Extreme 1401.9
1,643
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 29/02/2024
Director of Finance/CFO - 03/07/2024
Compliance Officer - 13/03/2023
Director TitleAgeSince
Chairman 65 21/09/2025
Director/Board Member 54 29/02/2024
Director/Board Member 66 26/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
-1.77%-3.66%-23.09% - 1.7B
-6.60%-8.56%+49.38%+63.51% 65B
+0.03%+5.56%+9.10%+69.05% 51.2B
-4.09%-0.11%+2.22%+53.15% 51.19B
-1.53%+2.70%+30.48%+34.12% 43.93B
-1.34%+4.12%+16.64%+115.13% 41.96B
-5.97%-6.22%+228.95%+454.22% 38.14B
+6.53%+8.02%+16.40%+53.41% 33.24B
-0.90%-10.49%+37.09%-3.70% 25.2B
-1.07%+2.33%+19.43%+9.98% 22.5B
Average -1.67%-0.68%+38.66%+94.32% 37.41B
Weighted average by Cap. -2.19%-0.51%+43.94%+96.53%

Financials

2027 *2028 *
Net sales 21.8B 230M 204M 189M 172M 325M 330M 2.27B 892M 11.38B 862M 844M 36.26B 34.02B 358M 319M 295M 269M 507M 515M 3.55B 1.39B 17.75B 1.35B 1.32B 56.59B
Net income 4.46B 46.98M 41.76M 38.71M 35.22M 66.46M 67.52M 465M 182M 2.33B 176M 173M 7.42B 8.97B 94.5M 84M 77.86M 70.84M 134M 136M 936M 367M 4.68B 355M 347M 14.92B
Net Debt 8.86B 93.31M 82.95M 76.88M 69.95M 132M 134M 924M 362M 4.62B 350M 343M 14.73B 1.16B 12.26M 10.9M 10.1M 9.19M 17.35M 17.63M 121M 47.62M 607M 46.03M 45.05M 1.94B
Projected Income Statement - Annual - OneSource Specialty Pharma Limited
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based Contract Development and Manufacturing Organization (CDMO). The Company offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply. The Company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. Its integrated services offer comprehensive biologics solutions. The Company develops a variety of soft gelatin capsules including traditional and enteric softgels, vegan capsule alternatives, chewable formats and specialty dosage forms, and liposomal systems and applicaps. It also provides end-to-end development and manufacturing of sterile injectable products.
Employees
1,674
Date Price Change Volume
16/10/26 ₹1,407.80 -1.77% 103,563
15/10/26 ₹1,433.20 -0.64% 85,979
14/10/26 ₹1,442.40 -1.14% 303,380
13/10/26 ₹1,459.10 -0.81% 228,818
12/10/26 ₹1,471.00 +0.66% 167,234
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - OneSource Specialty Pharma Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,407.80INR
Average target price
2,056.00INR
Spread / Average Target
+46.04%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OneSource Specialty Pharma Limited
  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock